Skip to content

Evaluation of the effect of topical Sesame Oil in the Prevention of Chemotherapy-Induced Phlebitis in 17 Shahrivar Hospital

Evaluation of the effect of topical Sesame Oil in the Prevention of Chemotherapy-Induced Phlebitis in 17 Shahrivar Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015101924594N1
Enrollment
60
Registered
2015-11-12
Start date
2015-11-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phlebitis. Vascular complications following infusion, transfusion and therapeutic injection

Interventions

Intervention 1: Intervention 1: 10 drops of Sesame oil for external using, every 12 hours, two times a day, from the first day of chemotherapy up to the thirtieth day. Intervention 2: In control group
Prevention
Intervention 1: 10 drops of Sesame oil for external using, every 12 hours, two times a day, from the first day of chemotherapy up to the thirtieth day.
In control group paraffin as placebo. The amount and method of using liquid paraffin is as exactly same as using of sesame oil in the experimental group.

Sponsors

Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: consciousness; age 1-14 years; admitted to hospital with ALL; chemotherapeutic management with Adriamycin & vincristine; Application No. 22-24 catheter medifllon Company; catheterization into arm vein; No septic conditions during catheterization; Underlying Co-morbidity (diabetes, infections, and hypertension); underlying fever and neutropenia; any broad spectrum antibiotic & narcotic analgesic in the patient medication instructions no received antibiotic & narcotic analgesic; received another Vegetable oil or drug; history of Sesame family allergy. Exclusion criteria: Vessel rupture due to nursing error; Lack of chemotherapy drugs under the skin and surrounding tissues.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Phlebitis. Timepoint: Daily. Method of measurement: visual infusion phlebitis scale.

Secondary

MeasureTime frame
Pain, Erythema, Swelling. Timepoint: Daily. Method of measurement: visual infusion phlebitis scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Zahra Shafipour

Guilan University of Medical Sciences

shafipur@gums.ac.ir+98 13 3355 5056

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026